Laboratory markers of urinary tract infection in children: current state and prospects

Urinary tract infection (UTI) is a common and important clinical problem in all age groups. Diagnosis of UTI without localization is not difficult, while the differential diagnosis of UTI is complicated by the lack of specific criteria for pyelonephritis and cystitis. The presence of certain clinical symptoms in combination with a positive bacteriological examination of urine does not allow us to reliably determine the localization of the inflammatory process in the urinary system, which is important due to the different approaches to the treatment of pyelonephritis and cystitis. The review considers in detail the data of studies demonstrating insufficient sensitivity and specificity of the accepted markers of urinary tract infection. Studies have found that ESR and CRP cannot act as specific markers for UTI, especially in children with fever. It has been shown that the procalcitonin test can be considered as such a marker, however, a limited number of studies and a noticeable heterogeneity between studies do not allow us to state this fact definitely. In this regard, it is necessary to search for modern, more accurate biomarkers, that allow differentiating pyelonephritis and cystitis at the earliest stages. The article presents data of modern studies, demonstrating the role of cytokines as biomarkers of UTI, showing their role in differentiating UTI of the lower and upper parts. In addition, the potential role of antimicrobial peptides as diagnostic markers of UTI is considered.

1. Khoshnood S., Heidary M., Mirnejad R., Bahramian A., Sedighi M., Mirzaei H. Drug-resistant gram-negative uropathogens: A review. Biomed Pharmacother. 2017;94:982–994. https://doi.org/10.1016/j.biopha.2017.08.006.

2. Kumar M.S., Das A.P. Emerging nanotechnology based strategies for diagnosis and therapeutics of urinary tract infections: a review. Adv Colloid Interface Sci. 2017;249:53–65. https://doi.org/10.1016/j.cis.2017.06.010.

3. Rafalsky V.V., Moiseeva E.M. Еpidemiology of uncomplicated outpatient urinary tract infections in the Russian Federation. Urology Herald. 2018;(2):30–37. (In Russ.) https://doi.org/org/10.21886/2308-6424-2018-6-2-30-37.

4. Spencer J.D., Schwaderer A., McHugh K., Hains D.S. Pediatric urinary tract infections: an analysis of hospitalizations, charges, and costs in the USA. Pediatr Nephrol. 2010;25(12):2469–2475. https://doi.org/10.1007/s00467-010-1625-8.

5. Brandstrom P., Hansson S. Long-term, low-dose prophylaxis against urinary tract infections in young children. Pediatr Nephrol. 2015;30(3):425–432. https://doi.org/10.1007/s00467-014-2854-z.

6. Chugunova O.L., Shumikhina M.V. Infection of the urinary system in children: current issues. Effective Pharmacotherapy. 2015;(22):10–21. (In Russ.) Available at: https://umedp.ru/articles/infektsiya_mochevoy_sistemy_u_detey_aktualnye_voprosy.html.

7. Stein R., Dogan H.S., Hoebeke P., Kočvara R., Nijman R.J., Radmayr C., Tekgül S. Urinary tract infections in children: EAU/ESPU guidelines. Eur Urol. 2015;67(3):546–558. https://doi.org/10.1016/j.eururo.2014.11.007.

8. Baranov A.A., Kozlov R.S., Namazova-Baranova L.S., Andreeva I.V., Vishneva E.I., Zakirov N.Z. et al. Urinary tract infection in children: clinical guidelines. Moscow; 2021. 54 р. (In Russ.) Available at: https://cr.minzdrav.gov.ru/schema/281_2.

9. Knottnerus B.J., Geerlings S.E., Moll van Charante E.P., Ter Riet G. Toward a simple diagnostic index for acute uncomplicated urinary tract infections. Ann Fam Med. 2013;11(5):442–451. https://doi.org/10.1370/afm.1513.

10. Colgan R., Jaffe G.A., Nicolle L.E. Asymptomatic Bacteriuria. Am Fam Physician. 2020;102(2):99–104. Available at: https://pubmed.ncbi.nlm.nih.gov/32667160.

11. Zakharova I.N., Osmanov I.M., Mumladze E.B., Machneva E.B., Tambieva E.V., Mekburzaeva G.B. Asymptomatic bacteriuria: change of the common opinion. Meditsinskiy Sovet. 2017;(19):162–167. (In Russ.) https://doi.org/10.21518/2079-701X-2017-19-162-167.

12. Sobel J.D., Kaye D. 74 – Urinary Tract Infections. In: Bennett J.E., Dolin R., Blaser M.J. (eds.). Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 8th ed. Elsevier Inc.; 2015. Vol. 1, pp. 886–913.e3. https://doi.org/10.1016/B978-1-4557-4801-3.00074-6.

13. Biggi A., Dardanelli L., Pomero G., Cussino P., Noello C., Sernia O. et al. Acute renal cortical scintigraphy in children with a first urinary tract infection. Pediatr Nephrol. 2001;16(9):733–738. https://doi.org/10.1007/s004670100657.

14. Lin D.S., Huang S.H., Lin C.C., Tung Y.C., Huang T.T., Chiu N.C. et al. Urinary tract infection in febrile infants younger than eight weeks of age. Pediatrics. 2000;105(2):E20. https://doi.org/10.1542/peds.105.2.e20.

15. Gürgöze M.K., Akarsu S., Yilmaz E., Gödekmerdan A., Akça Z., Ciftçi I., Aygün A.D. Proinflammatory cytokines and procalcitonin in children with acute pyelonephritis. Pediatr Nephrol. 2005;20(10):1445–1448. https://doi.org/10.1007/s00467-005-1941-6.

16. Assicot M., Gendrel D., Carsin H., Raymond J., Guilbaud J., Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341(8844):515–518. https://doi.org/10.1016/0140-6736(93)90277-n.

17. Xu R.Y., Liu H.W., Liu J.L., Dong J.H. Procalcitonin and C-reactive protein in urinary tract infection diagnosis. BMC Urol. 2014;14:45. https://doi.org/10.1186/1471-2490-14-45.

18. Ayazi P., Abolfazl M., Hassan J.H., Mohammad M.D., Toktam K., Fatemeh S. Comparison of procalcitonin and C-reactive protein tests in children with urinary tract infection. Iran J Pediatr. 2009;19(4):381–386. Available at: http://www.bioline.org.br/pdf?pe09045.

19. Shaikh K.J., Osio V.A., Leeflang M.M., Shaikh N. Procalcitonin, C-reactive protein, and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children. Cochrane Database Syst Rev. 2020;9(9):CD009185. https://doi.org/10.1002/14651858.CD009185.pub3.

20. Abraham S.N., Miao Y. The nature of immune responses to urinary tract infections. Nat Rev Immunol. 2015;15(10):655–663. https://doi.org/10.1038/nri3887.

21. Ragnarsdóttir B., Svanborg C. Susceptibility to acute pyelonephritis or asymptomatic bacteriuria: host-pathogen interaction in urinary tract infections. Pediatr Nephrol. 2012;27(11):2017–2029. https://doi.org/10.1007/s00467-011-2089-1.

22. Ching C.B., Gupta S., Li B., Cortado H., Mayne N., Jackson A.R. et al. Interleukin-6/Stat3 signaling has an essential role in the host antimicrobial response to urinary tract infection. Kidney Int. 2018;93(6):1320–1329. https://doi.org/10.1016/j.kint.2017.12.006.

23. Ching C., Schwartz L., Spencer J.D., Becknell B. Innate immunity and urinary tract infection. Pediatr Nephrol. 2020;35(7):1183–1192. https://doi.org/10.1007/s00467-019-04269-9.

24. Dixit A., Bottek J., Beerlage A.L., Schuettpelz J., Thiebes S., Brenzel A. et al. Frontline Science: Proliferation of Ly6C+ monocytes during urinary tract infections is regulated by IL-6 trans-signaling. J Leukoc Biol. 2018;103(1):13–22. https://doi.org/10.1189/jlb.3HI0517-198R.

25. Owusu-Boaitey N., Bauckman K.A., Zhang T., Mysorekar I.U. Macrophagic control of the response to uropathogenic E. coli infection by regulation of iron retention in an IL-6-dependent manner. Immun Inflamm Dis. 2016;4(4):413–426. https://doi.org/10.1002/iid3.123.

26. Weichhart T., Haidinger M., Hörl W.H., Säemann M.D. Current concepts of molecular defence mechanisms operative during urinary tract infection. Eur J Clin Invest. 2008;38(2 Suppl.):29–38. https://doi.org/10.1111/j.1365-2362.2008.02006.x.

27. Rodríguez L.M., Robles B., Marugán J.M., Suárez A., Santos F. Urinary interleukin-6 is useful in distinguishing between upper and lower urinary tract infections. Pediatr Nephrol. 2008;23(3):429–433. https://doi.org/10.1007/s00467-007-0670-4.

28. Godaly G., Hang L., Frendéus B., Svanborg C. Transepithelial neutrophil migration is CXCR1 dependent in vitro and is defective in IL-8 receptor knockout mice. J Immunol. 2000;165(9):5287–5294. https://doi.org/10.4049/jimmunol.165.9.5287.

29. Frendéus B., Godaly G., Hang L., Karpman D., Lundstedt A.C., Svanborg C. Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart. J Exp Med. 2000;192(6):881–890. https://doi.org/10.1084/jem.192.6.881.

30. Han S.S., Lu Y., Chen M., Xu Y.Q., Wang Y. Association between interleukin 8-receptor gene (CXCR1 and CXCR2) polymorphisms and urinary tract infection: Evidence from 4097 subjects. Nephrology (Carlton). 2019;24(4):464–471. https://doi.org/10.1111/nep.13260.

31. Al Rushood M., Al-Eisa A., Al-Attiyah R. Serum and urine interleukin-6 and interleukin-8 levels do not differentiate acute pyelonephritis from lower urinary tract infections in children. J Inflamm Res. 2020;13:789–797. https://doi.org/10.2147/JIR.S275570.

32. Sundén F., WulltB. Predictive value of urinary interleukin-6 for symptomatic urinary tract infections in a nursing home population. Int J Urol. 2016;23(2):168–174. https://doi.org/10.1111/iju.13002.

33. Mazaheri M. Serum interleukin-6 and interleukin-8 are sensitive markers for early detection of pyelonephritis and its prevention to progression to chronic kidney disease. Int J Prev Med. 2021;12:2. https://doi.org/10.4103/ijpvm.IJPVM_50_19.

34. Azab S., Zakaria M., Raafat M., Seief H. The combination of urinary IL-6 and renal biometry as useful diagnostic tools to differentiate acute pyelonephritis from lower urinary tract infection. Int Braz J Urol. 2016;42(4):810–816. https://doi.org/10.1590/S1677-5538.IBJU.2016.0049.

35. Sheu J.N., Chen M.C., Lue K.H., Cheng S.L., Lee I.C., Chen S.M., Tsay G.J. Serum and urine levels of interleukin-6 and interleukin-8 in children with acute pyelonephritis. Cytokine. 2006;36(5–6):276–282. https://doi.org/10.1016/j.cyto.2007.02.006.

36. Sheu J.N., Chen M.C., Cheng S.L., Lee I.C., Chen S.M., Tsay G.J. Urine interleukin-1beta in children with acute pyelonephritis and renal scarring. Nephrology (Carlton). 2007;12(5):487–493. https://doi.org/10.1111/j.1440-1797.2007.00819.x.

37. Demidova K.N., Morozov D.A., Rostovskaya V.V., Morozova O.L., Staroverov O.V., Shmyrov O.S. Mathematical analysis of individual biomarker profiles of kidney damage in children with vesicoureteral reflux. Clinical Practice in Pediatrics. 2022;(1):43–52. (In Russ.) https://doi.org/10.20953/1817-7646-2022-1-43-52.

38. Ziaei K.T., Valavi E., Nikfar R., Najafi R., Forouzan A., Heidari M.H. Diagnostic accuracy of interleukin-8 in differentiation of acute pyelonephritis from cystitis in children. Asian J Cell Biol. 2015;(10):57–65. https://doi.org/10.3923/ajcb.2015.57.65.

39. Drage L.K.L., Robson W., Mowbray C., Ali A., Perry J.D., Walton K.E. et al. Elevated urine IL-10 concentrations associate with Escherichia coli persistence in older patients susceptible to recurrent urinary tract infections. Immun Ageing. 2019;16:16. https://doi.org/10.1186/s12979-019-0156-9.

40. Zakharova I.N., Osmanov I.M., Klimov L.Y., Kasyanova A.N., Kuryaninova V.A., Lupan I.N. The role of antimicrobial peptides in defending the urinary tract against infections. Meditsinskiy Sovet. 2019;(2):143–150. (In Russ.) https://doi.org/10.21518/2079-701X-2019-2-143-150.

41. Spencer J.D., Hains D.S., Porter E., Bevins C.L., Dirosario J., Becknell B. et al. Human alpha defensin 5 expression in the human kidney and urinary tract. PLoS ONE. 2012;7(2):e31712. https://doi.org/10.1371/journal.pone.0031712.

42. Ihi T., Nakazato M., Mukae H., Matsukura S. Elevated concentrations of human neutrophil peptides in plasma, blood, and body fluids from patients with infections. Clin Infect Dis. 1997;25(5):1134–1140. https://doi.org/10.1086/516075.

43. Tikhonov I., Rebenok A., Chyzh A. A study of interleukin-8 and defensins in urine and plasma of patients with pyelonephritis and glomerulonephritis. Nephrol Dial Transplant. 1997;12(12):2557–2561. https://doi.org/10.1093/ndt/12.12.2557.

44. Lehmann J., Retz M., Harder J., Krams M., Kellner U., Hartmann J. et al. Expression of human beta-defensins 1 and 2 in kidneys with chronic bacterial infection. BMC Infect Dis. 2002;2:20. https://doi.org/10.1186/1471-2334-2-20.

45. Babikir I.H., Abugroun E.A., Naser E., Alghasham A.A., Abdalla E.E., Adam I. The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections. BMC Infect Dis. 2018;18(1):17. https://doi.org/10.1186/s12879-017-2901-z.

46. Gupta S., Jackson A.R., DaJusta D.G., McLeod D.J., Alpert S.A., Jayanthi V.R. et al. Urinary antimicrobial peptides: Potential novel biomarkers of obstructive uropathy. J Pediatr Urol. 2018;14(3):238.e1–238.e6. https://doi.org/10.1016/j.jpurol.2018.03.006.